News

Researchers have created a computational model that uses machine learning to fully analyze a patient’s tumor and better predict glioblastoma multiforme progression.

Scientists from the Netherlands Cancer Institute and Leiden University Medical Center have discovered the way in which specialized immune cells can detect and remove cancers that are "invisible" to the conventional defense mechanisms employed by the immune system.

A new program has been used to provide expert treatment guidance for more than 500 patients over a six-month evaluation period and has identified clinical trials appropriate for most of them.

The discovery of a protein – named Menin – that contributes to the abnormal deactivation of genes during cancer progression could help pave the way toward new lung cancer treatments.

According to a clinical trial, MRI-guided radiotherapy produces fewer side effects and better quality of life for patients with localized prostate cancer than computed tomography-guided radiotherapy.

Researchers at the Massachusetts General Hospital have identified a gene that is active in some treatment-resistant cancer cells, which when silenced, enhanced the cells' susceptibility to immunotherapy.

Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an effective but expensive medication.

Northwestern Medicine investigators have revealed new insights into how cancer cells can change their form by undergoing phenotypic “switches” to facilitate tumor growth and treatment resistance in small cell lung cancer.

Inflammation “risk scores” could aid decision-making on the best therapies for acute myeloid leukemia (AML).

Physicists have modeled cell migration, showing how cancer cells distinguish between soft and stiff surfaces as they navigate tissues during metastasis.